Associate ProfessorMedicine Division HeadCyrus E. Rubin Endowed Chair in MedicineDivision of GastroenterologyFaculty Information Biography Rotonya McCants Carr, MD is the Cyrus E. Rubin Chair and Division Head of Gastroenterology at the University of Washington. She is a basic science researcher and clinical hepatologist who specializes in the care of patients with fatty liver diseases. Her laboratory uses complementary in vivo and cellular approaches to investigate the mechanisms of insulin resistance in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD). Dr. Carr is a member of the American Gastroenterological Association, American Association for the Study of Liver Diseases, European Association for the Study of the Liver, Research Society of Alcoholism, founding member of the Association of Black Gastroenterologists and Hepatologists, and national board member of the American Liver Foundation. She is a former guest editor of Cellular and Molecular Gastroenterology and Hepatology and current editorial member of Hepatology, Liver Transplantation, and the Journal of Lipid Research. In 2020, Dr. Carr was honored as one of Cell’s most inspiring Black scientists. Board Certifications: Internal Medicine Recertification exam, 2014 Gastroenterology, 2011, American Board of Internal Medicine Internal Medicine, 2004, American Board of Internal Medicine Education & Training: Postdoctoral fellowshipUniversity of PennsylvaniaPhiladelphia, PA2009-2013 Fellowship in GastroenterologyHospital of the University of PennsylvaniaPhiladelphia, PA2008-2011 Resident in MedicineMassachusetts General HospitalBoston, MA2002-2004 Intern in MedicineMassachusetts General HospitalBoston, MA 2001-2002 Medical DoctorCornell University Medical CollegeIthaca, NY2001 Bachelor of Arts (Biology Cum Laude)Harvard UniversityCambridge, MA1996 Honors: Recipient of the Inaugural Lina Obeid Junior Investigator Award.2021 Fellow of the American College of Physicians2021 National Board of the American Liver Foundation2021 Recognized by Cell in their inaugural list of "100 Inspiring Black Scientists in America"2020 AASLD 2020 Poster of Distinction2020 NIH CSR special emphasis panel study section2020 Leadership Enhancement 2.0 Fellow, University of Pennsylvania2019 NIAAA AA-1 Study Section Standing Member2018-2022 Additional honors spanning1992-2018 Contact Email: rmcarr@medicine.washington.eduMailing Address: 1959 NE Pacific St, Box 356424 Seattle, WA 98195 Research & Clinical Interests Research Interests: Mechanisms of insulin resistance in non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD) The Carr lab aims to understand how dysregulation of hepatic metabolism promotes liver disease. Our current projects involve investigating the role of lipid metabolites and lipid droplet proteins in impairing hepatic insulin signaling, a key event in the earliest stage of several metabolic liver diseases. Our lab combines molecular biology techniques, genetic models, and comprehensive in vivo physiologic studies to uncover the pathophysiologic basis of metabolic liver diseases. Studies performed in the lab form the basis for translational studies investigating the prognostic and pathologic role of lipids and lipid associated proteins. Clinical Interests: Fatty liver diseases Publications PubMed: PubMed Bibliography
